FDA Arthritis Advisory Committee meeting: postmarketing surveillance of nonsteroidal antiinflammatory drugs. (Q54737121): Preview

FDA Arthritis Advisory Committee meeting: postmarketing surveillance of nonsteroidal antiinflammatory drugs. (Q54737121)
scientific article

Language:

(P31)

(Q13442814)

(P248)
(P698)	4052129
(P813)	Sunday, June 3, 2018
(P854)	http://europepmc.org/abstract/MED/4052129

(P304)

1168-1169

(P248)
(P698)	4052129
(P813)	Sunday, June 3, 2018
(P854)	http://europepmc.org/abstract/MED/4052129

(P433)

(P248)
(P698)	4052129
(P813)	Sunday, June 3, 2018
(P854)	http://europepmc.org/abstract/MED/4052129

(P478)

(P248)
(P698)	4052129
(P813)	Sunday, June 3, 2018
(P854)	http://europepmc.org/abstract/MED/4052129

(P577)

Tuesday, October 1, 1985

(P248)
(P698)	4052129
(P813)	Sunday, June 3, 2018
(P854)	http://europepmc.org/abstract/MED/4052129

(P1433)

(Q23929027)

(P248)
(P698)	4052129
(P813)	Sunday, June 3, 2018
(P854)	http://europepmc.org/abstract/MED/4052129

(P1476)

"FDA Arthritis Advisory Committee meeting: postmarketing surveillance of nonsteroidal antiinflammatory drugs." (language: en)

(P248)
(P698)	4052129
(P813)	Sunday, June 3, 2018
(P854)	http://europepmc.org/abstract/MED/4052129

(P2093)

Paulus HE

(P1545)	1

(P248)
(P698)	4052129
(P813)	Sunday, June 3, 2018
(P854)	http://europepmc.org/abstract/MED/4052129

other details

description	scientific article

External Links